カテゴリ： MarketsandMarkets, 世界, 医療/バイオ

脳モニタリングの世界市場予測（～2028）：機器別、付属品別、モダリティ別、疾患別、エンドユーザー別

■ 英語タイトル：Brain Monitoring Market by Devices (EEG, EMG, MEG, ICP, MRI, fMRI, CT) Accessories (Electrode, Sensor), Modality (Portable, Wearable), Indication (Stroke, TBI, Epilepsy, Headache, Sleep), End User (Hospital, Neurology center) - Global Forecast to 2028

調査会社MarketsandMarkets社が発行したリサーチレポート（データ管理コード：MD1369-24）■ 発行会社/調査会社：MarketsandMarkets
■ 商品コード：MD1369-24
■ 発行日：2024年1月16日
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：336
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥702,900見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥944,300見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,157,300見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[脳モニタリングの世界市場予測（～2028）：機器別、付属品別、モダリティ別、疾患別、エンドユーザー別]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

“世界の脳モニタリング市場規模は、2023年の35億米ドルから2028年には48億米ドルになると推定され、年平均成長率は6.3％”脳モニタリング市場は、主に神経疾患の増加、神経変性疾患に関する認知度の向上、外傷性脳損傷の急増、臨床試験における脳モニタリングの利用拡大が推進力となっています。さらに、非侵襲性・低侵襲性デバイスに対する需要の高まり、脳モニタリングツールの治療用途の拡大、新興国における医療セクターの急成長も、市場の追い風となるでしょう。逆に、複雑な脳モニタリング手順や機器に関連する高額な費用、不利な償還政策、脳モニタリング機器を効果的に操作できる熟練した専門家の不足などの課題は、市場の成長を阻害します。

“2022年の脳モニタリング機器市場シェアはデバイス分野が最大になる見込み”
製品別に見ると、世界の脳モニタリング市場はデバイスとアクセサリに分類されます。デバイスセグメントは2022年に脳モニタリング市場で最大のシェアを占める見込みです。これは主に、早期診断の必要性とともに、神経学的、神経変性、精神病、睡眠障害の発生が増加していること、家庭用に設計された革新的なポータブルおよびウェアラブルモニタリングデバイスの存在、患者の意識の高まりによるものです。

“予測期間中に最も高い成長率を記録する電極セグメント”
予測期間において最も高い成長率を記録すると予想されるのは電極分野です。技術の進歩により、電極と組織のインターフェースが改善され、コスト効率が高く、高機能な電極の開発が可能になりました。さらに、使い捨て電極の統合は、その受容性とこの市場セグメントの拡大を大幅に推進しました。

“脳モニタリング市場のモダリティセグメントで最大のシェアを占める固定デバイス”
モダリティ別に見ると、世界の脳モニタリング市場は固定型、ポータブル型、ウェアラブル型に分類されます。2022年の脳モニタリング市場で最大のシェアを占めたのは固定型デバイスです。病院、専門医療センター、研究機関のような臨床環境での利用が確立されているため、これらの固定機器は一般的に包括的な脳モニタリングのベンチマークとみなされています。その評判は、その精度、信頼性、洗練された機能から生じています。
2022年の脳モニタリング市場では、外傷性脳損傷分野が最大のシェアを占めています。
医学的状態に基づいて、脳モニタリング市場は、外傷性脳損傷（TBI）、脳卒中、認知症、頭痛障害、睡眠障害、パーキンソン病、てんかん、ハンチントン病、およびその他の疾患にセグメント化されます。外傷性脳損傷（TBI）は、病状別脳モニタリング市場で最大のシェアを占めています。このセグメントの市場シェアを大幅に押し上げている主な要因は、世界的な外傷性脳損傷（TBI）の顕著な増加です。このようなTBIの増加は、これらの症例を管理するための大きなニーズを生み出し、それによって脳モニタリングデバイスの広範な使用を必要とします。


“予測期間中、北米が脳モニタリング市場で最大の地域セグメントに”
地域別に見ると、世界の脳モニタリング市場は北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東・アフリカに分けられます。北米は2022年に世界の脳モニタリング市場で最大のシェアを占めると予測され、アジア太平洋は予測期間中に最も急成長する地域と予測されています。アジアでの市場拡大は、高齢者人口の拡大、安価な熟練労働力へのアクセス、可処分所得の増加、神経変性疾患の罹患率の増加、同地域における医療改革に対する政府の関心の高まりなど、いくつかの要因に起因しています。

主要参加者の内訳

主な参加企業の内訳は以下の通りです：

- 企業タイプ別 - ティア1：35％、ティア2：45％、ティア3：20％
- 役職別 - Cレベル：35％、ディレクターレベル：25％、その他：40％
- 地域別 - 北米：45％、ヨーロッパ：30％、アジア太平洋：20％、中南米：3％、中東・アフリカ：2％

脳モニタリング市場は、Cadwell Industries (US), NeuroWave Systems, Inc. (US), Nonin Medical, Inc. (US), Natus Medical, Inc. (US), Nihon Kohden Corporation (Japan), Masimo Corporation (US), Unilabs Holdings AB (Sweden), Philips Healthcare (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), Compumedics, Ltd. (Australia), Medtronic (Ireland), Luciole Meidcal AG (Switzerland), Drägerwerk AG & Co. KGaA (Germany), Advanced Brain Monitoring (US), Integra LifeSciences Corporation (US), and Neurosoft (Russia)などが挙げられます。

調査範囲

本レポートでは、脳モニタリング市場を地域（アジア太平洋、ヨーロッパ、北米、中南米、中東・アフリカ）、製品（デバイスとアクセサリ）、手順（侵襲的、非侵襲的）、モダリティ（固定式、ウェアラブル、ポータブル）、 疾患タイプ（外傷性脳損傷（TBI）、脳卒中、認知症、頭痛障害、睡眠障害、パーキンソン病、てんかん、ハンチントン病、その他の疾患）、エンドユーザー（病院、神経センター、診断センター、ASC＆クリニック、その他のエンドユーザー）に区分しています。
また、脳モニタリング市場の市場促進要因、阻害要因、機会に関する包括的なレビューも提供しています。

レポート購入の主な利点

本レポートは、市場全体とサブセグメントの収益数の最も近い近似値に関する情報を提供し、この市場のリーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得ることで、事業の位置づけを高め、適切な市場参入戦略を計画するのに役立ちます。また、本レポートは、関係者が脳モニタリング市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

レポート購入の理由

本レポートは、既存企業だけでなく、新規参入企業や小規模企業が市場の脈拍を測定するのに役立ちます。本レポートを購入された企業は、以下の戦略のいずれか、または任意の組み合わせを使用して、市場での地位を強化することができます。

本レポートでは、以下のポイントに関する洞察を提供しています：
o 主な促進要因（神経疾患の罹患率および有病率の増加、神経変性疾患に対する意識の高まり、外傷性脳損傷の罹患率の増加）、阻害要因（複雑な脳モニタリング手順およびデバイスの高コスト、不利な償還政策）、機会（非侵襲性および低侵襲性デバイスの需要の増加）、課題（脳モニタリングデバイスを効果的に操作するための訓練を受けた専門家の不足）の分析しました。
o 市場浸透度： 世界の脳モニタリング市場におけるトップ企業が提供する製品ポートフォリオに関する包括的な情報を記載しています。製品別、手技別、モダリティ別、病状別、エンドユーザー別に市場を分析しています。
o 製品の強化/革新： 脳モニタリングの世界市場における今後の動向と製品発売に関する詳細な洞察を提供します。
o 市場開発： 製品、手順、モダリティ、病状、エンドユーザー別の有利な新興市場に関する包括的な情報を記載しています。
o 市場の多様化： 世界の脳モニタリング市場における新製品や製品強化、成長地域、最近の開発、投資に関する詳細情報を記載しています。
o 競合評価： 脳モニタリングの世界市場における主要企業の市場シェア、成長戦略、製品提供、競合のリーダーシップマッピング、能力を詳細に評価します。

1.　序論
2.　調査方法
3.　エグゼクティブサマリー
4.　プレミアムインサイト
5.　市場概要
6.　世界の脳モニタリング市場規模：製品別
7.　世界の脳モニタリング市場規模：処置別
8.　世界の脳モニタリング市場規模：モダリティ別
9.　世界の脳モニタリング市場規模：病状別
10.　世界の脳モニタリング市場規模：エンドユーザー別
11.　世界の脳モニタリング市場規模：地域別
12.　競争状況
13.　企業情報
14.　付録

*** レポート目次（コンテンツ）***

1 INTRODUCTION 43
1.1 STUDY OBJECTIVES 43
1.2 MARKET DEFINITION 43
1.3 INCLUSIONS & EXCLUSIONS 44
1.4 MARKET SCOPE 45
1.4.1 MARKETS COVERED 45
FIGURE 1 MARKET SEGMENTATION 45
1.4.2 REGIONS COVERED 46
FIGURE 2 REGIONAL SEGMENTATION 46
1.4.3 YEARS CONSIDERED 46
1.4.4 CURRENCY CONSIDERED 47
1.5 STAKEHOLDERS 47
1.6 RESEARCH LIMITATIONS 47
1.6.1 SCOPE-RELATED LIMITATIONS 47
1.6.2 METHODOLOGY-RELATED LIMITATIONS 47
1.7 SUMMARY OF CHANGES 47
1.7.1 IMPACT OF RECESSION 48
2 RESEARCH METHODOLOGY 49
2.1 RESEARCH DATA 49
FIGURE 3 RESEARCH DESIGN 49
2.1.1 SECONDARY DATA 50
2.1.1.1 Key data from secondary sources 50
2.1.2 PRIMARY DATA 51
FIGURE 4 PRIMARY SOURCES 51
2.1.2.1 Key data from primary sources 52
2.1.2.2 Insights from primary experts 53
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 53
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION 54
2.2 MARKET SIZE ESTIMATION 54
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 55
FIGURE 8 COMPANY REVENUE ESTIMATION: NATUS MEDICAL, INC. (2022) 56
FIGURE 9 MARKET REVENUE ESTIMATION: EEG MARKET 56
FIGURE 10 BOTTOM-UP APPROACH 57
FIGURE 11 TOP-DOWN APPROACH 59
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN BRAIN MONITORING MARKET (2023–2028) 60
FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 61
TABLE 1 MARKET ASSESSMENT FACTOR ANALYSIS 62
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 63
FIGURE 14 DATA TRIANGULATION METHODOLOGY 63
2.4 STUDY ASSUMPTIONS 64
2.5 RISK ASSESSMENT 64
TABLE 2 RISK ASSESSMENT: BRAIN MONITORING MARKET 64
2.6 IMPACT OF ECONOMIC RECESSION ON BRAIN MONITORING MARKET 65
3 EXECUTIVE SUMMARY 66
FIGURE 15 BRAIN MONITORING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 66
FIGURE 16 BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2023 VS. 2028 (USD MILLION) 67
FIGURE 17 BRAIN MONITORING MARKET, BY PROCEDURE, 2023 VS. 2028 (USD MILLION) 67
FIGURE 18 BRAIN MONITORING MARKET, BY MODALITY, 2023 VS. 2028 (USD MILLION) 68
FIGURE 19 BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2023 VS. 2028 (USD MILLION) 68
FIGURE 20 BRAIN MONITORING MARKET, BY END USER, 2023–2028 (USD MILLION) 69
FIGURE 21 REGIONAL SNAPSHOT: BRAIN MONITORING MARKET 70
4 PREMIUM INSIGHTS 71
4.1 BRAIN MONITORING MARKET OVERVIEW 71
FIGURE 22 INCREASING INCIDENCE AND PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET 71
4.2 BRAIN MONITORING MARKET, BY REGION 72
FIGURE 23 NORTH AMERICA TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD 72
4.3 BRAIN MONITORING MARKET, BY PROCEDURE 73
FIGURE 24 NON-INVASIVE PROCEDURES AND JAPAN HELD LARGEST MARKET SHARE IN 2022 73
4.4 GEOGRAPHIC SNAPSHOT: BRAIN MONITORING MARKET 74
FIGURE 25 CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD 74
4.5 DEVELOPED VS. EMERGING ECONOMIES: BRAIN MONITORING MARKET 75
FIGURE 26 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD 75
5 MARKET OVERVIEW 76
5.1 INTRODUCTION 76
5.2 MARKET DYNAMICS 76
FIGURE 27 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: BRAIN MONITORING MARKET 76
5.2.1 DRIVERS 77
5.2.1.1 Increasing incidence and prevalence of neurological disorders 77
5.2.1.2 Rising awareness of neurodegenerative disorders 78
5.2.1.3 Growing incidence of traumatic brain injuries 78
5.2.1.4 Increased applications of brain monitoring devices in clinical trials 79
5.2.2 RESTRAINTS 79
5.2.2.1 High cost of complex brain monitoring procedures and devices 79
5.2.2.2 Unfavorable reimbursement policies 80
5.2.3 OPPORTUNITIES 80
5.2.3.1 Increasing demand for non-invasive and minimally-invasive brain monitoring devices 80
5.2.3.2 Expanding therapeutic applications of brain monitoring devices 81
5.2.3.3 Growing healthcare market in emerging economies 81
5.2.4 CHALLENGES 82
5.2.4.1 Shortage of trained medical professionals 82
5.2.4.2 Complex regulatory process and compliance framework 83
5.3 INDUSTRY TRENDS 83
5.3.1 GRADUAL SHIFT TO VALUE-BASED AND PATIENT-CENTRIC CARE 83
5.3.2 INNOVATIONS IN WEARABLE MEDICAL TECHNOLOGY 84
5.4 PRICING ANALYSIS 84
TABLE 3 REGIONAL PRICING ANALYSIS OF KEY BRAIN MONITORING DEVICES 85
TABLE 4 AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER (2022) 85
5.5 VALUE CHAIN ANALYSIS 86
5.5.1 RESEARCH & PRODUCT DEVELOPMENT 86
5.5.2 RAW MATERIAL PROCUREMENT 86
5.5.3 MANUFACTURING 86
5.5.4 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 86
FIGURE 28 VALUE CHAIN ANALYSIS: BRAIN MONITORING MARKET 86
5.6 ECOSYSTEM MARKET/MAP 87
FIGURE 29 ECOSYSTEM MARKET/MAP: BRAIN MONITORING MARKET 87
5.7 PORTER’S FIVE FORCES ANALYSIS 88
TABLE 5 PORTER’S FIVE FORCES ANALYSIS: BRAIN MONITORING MARKET 88
5.7.1 THREAT OF NEW ENTRANTS 88
5.7.2 THREAT OF SUBSTITUTES 88
5.7.3 BARGAINING POWER OF SUPPLIERS 89
5.7.4 BARGAINING POWER OF BUYERS 89
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 89
5.8 TARIFF & REGULATORY ANALYSIS 89
5.8.1 TARIFF FOR BRAIN MONITORING DEVICES 89
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 6 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
5.8.3 REGULATORY ANALYSIS 91
5.8.3.1 North America 91
5.8.3.1.1 US 91
TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION 91
TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 92
5.8.3.1.2 Canada 92
5.8.3.2 Europe 92
5.8.3.3 Asia Pacific 93
5.8.3.3.1 Japan 93
TABLE 9 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 93
5.8.3.3.2 China 93
5.8.3.3.3 India 94
5.9 TECHNOLOGY ANALYSIS 95
5.10 PATENT ANALYSIS 95
5.10.1 PATENT PUBLICATION TRENDS 95
5.10.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BRAIN MONITORING PATENTS 96
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BRAIN MONITORING PATENTS, 2011–2023 96
5.10.3 MAJOR PATENTS IN BRAIN MONITORING MARKET 97
FIGURE 31 MAJOR PATENTS FOR BRAIN MONITORING DEVICES (2011–2023) 97
5.11 TRADE ANALYSIS 99
FIGURE 32 PRODUCT IMPORTS UNDER HSN CODE: 901819, BY COUNTRY, 2022 (USD THOUSAND) 100
FIGURE 33 PRODUCT EXPORTS UNDER HSN CODE 901819, BY COUNTRY, 2022 (USD THOUSAND) 100
5.12 CASE STUDY ANALYSIS 101
TABLE 10 CASE STUDY 1: INTEGRATION OF GARMIN WEARABLE DEVICE DATA DIRECTLY INTO MEDTRONIC CARE MANAGEMENT SERVICES’ (MCMS) BRAIN MONITORING PLATFORM 101
TABLE 11 CASE STUDY 2: EPI-MINDER: A NOVEL IMPLANTABLE DEVICE FOR EPILEPSY MONITORING AND PREDICTION 101
5.13 KEY CONFERENCES & EVENTS, 2023–2024 102
TABLE 12 LIST OF KEY CONFERENCES & EVENTS IN BRAIN MONITORING MARKET, 2023–2024 102
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 103
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 103
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BRAIN MONITORING DEVICES 103
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BRAIN MONITORING DEVICES AND ACCESSORIES, BY TYPE 103
5.14.2 BUYING CRITERIA 104
FIGURE 34 KEY BUYING CRITERIA FOR BRAIN MONITORING DEVICES, BY TYPE 104
TABLE 15 KEY BUYING CRITERIA FOR BRAIN MONITORING DEVICES 104
5.15 UNMET NEEDS ANALYSIS & END USER EXPECTATIONS 104
TABLE 16 UNMET NEEDS IN BRAIN MONITORING MARKET 105
5.15.1 END USER EXPECTATIONS 105
TABLE 17 END USER EXPECTATIONS IN BRAIN MONITORING MARKET 106
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 107
FIGURE 35 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR BRAIN MONITORING MARKET 107
5.17 REIMBURSEMENT SCENARIO ANALYSIS 107
TABLE 18 CPT CODES AND REIMBURSEMENT ANALYSIS IN BRAIN MONITORING MARKET IN US 108
5.18 BUSINESS MODEL ANALYSIS 111
5.19 INVESTMENT AND FUNDING SCENARIO 112
FIGURE 36 INVESTOR DEALS AND FUNDING FOR BRAIN MONITORING DEVICES INCREASED IN 2022 112
FIGURE 37 VALUATION OF KEY FIRMS IN BRAIN MONITORING MARKET IN 2022 (USD MILLION) 112
6 BRAIN MONITORING MARKET, BY PRODUCT 113
6.1 INTRODUCTION 114
TABLE 19 BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 114
6.2 DEVICES 114
TABLE 20 BRAIN MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 21 BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 115
6.2.1 EEG DEVICES 116
6.2.1.1 Growing R&D in cerebral and spinal disorders and increasing number of EEG laboratories to drive segment 116
TABLE 22 EEG DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
6.2.2 TCD DEVICES 117
6.2.2.1 Rising prevalence of strokes and cerebrovascular disorders to aid market growth 117
TABLE 23 TCD DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
6.2.3 MEG DEVICES 118
6.2.3.1 High implementation and maintenance costs to limit market 118
TABLE 24 MEG DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
6.2.4 ICP MONITORS 119
6.2.4.1 Increasing incidence of traumatic brain injuries and post-surgical cerebrovascular complications to propel market 119
TABLE 25 ICP MONITORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
6.2.5 CEREBRAL OXIMETERS 120
6.2.5.1 Increasing cases of hypoxia during surgical procedures to drive segment 120
TABLE 26 CEREBRAL OXIMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
6.2.6 MRI SCANNERS 122
6.2.6.1 Technological advancements and rising number of neurological disorders to propel segment 122
TABLE 27 MRI SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
6.2.7 CT SCANNERS 123
6.2.7.1 Increasing preference for brain disease progression monitoring to drive segment 123
TABLE 28 CT SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
6.2.8 PET SCANNERS 124
6.2.8.1 Rising incidence of cancer to support market growth 124
TABLE 29 PET SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
6.2.9 SLEEP MONITORING DEVICES 125
6.2.9.1 Rising prevalence of sleep disorders to boost market growth 125
TABLE 30 SLEEP MONITORING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
6.2.10 EMG DEVICES 126
6.2.10.1 Increasing prevalence of neuromuscular diseases to aid market growth 126
TABLE 31 EMG DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
6.3 ACCESSORIES 128
TABLE 32 BRAIN MONITORING MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 128
6.3.1 BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE 129
TABLE 33 BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 129
6.3.1.1 Electrodes 129
TABLE 34 ELECTRODES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
6.3.1.1.1 Wet electrodes 130
6.3.1.1.1.1 Flexibility and high quality of signal recording to drive segment 130
TABLE 35 WET ELECTRODES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
6.3.1.1.2 Dry electrodes 131
6.3.1.1.2.1 Technological advancements and no requirement for skin preparation to aid market growth 131
TABLE 36 DRY ELECTRODES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
6.3.1.1.3 Needle electrodes 132
6.3.1.1.3.1 More accurate signals for diagnostic and therapeutic interventions to support market growth 132
TABLE 37 NEEDLE ELECTRODES MARKET, BY REGION, 2021–2028 (USD MILLION) 133
6.3.1.2 Sensors 133
6.3.1.2.1 Increasing patient preference for non-invasive procedures to drive market 133
TABLE 38 SENSORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
6.3.1.3 Pastes & gels 134
6.3.1.3.1 Increasing demand for non-invasive methods of brain monitoring to aid market growth 134
TABLE 39 PASTES & GELS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
6.3.1.4 Caps 135
6.3.1.4.1 Extended application of Infacaps for premature babies to propel segment 135
TABLE 40 CAPS MARKET, BY REGION, 2021–2028 (USD MILLION) 136
6.3.1.5 Batteries 136
6.3.1.5.1 Increasing usage of portable and rechargeable devices to support segment growth 136
TABLE 41 BATTERIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
6.3.1.6 Cables 137
6.3.1.6.1 Technological developments for increasing capabilities and cable lifespan to drive segment 137
TABLE 42 CABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 138
6.3.1.7 Other accessories 138
TABLE 43 OTHER ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
6.3.2 BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY 139
TABLE 44 BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 139
6.3.2.1 Disposable accessories 140
6.3.2.1.1 Growing physician preference for disposable accessories to propel market 140
TABLE 45 DISPOSABLE ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 140
6.3.2.2 Non-disposable accessories 141
6.3.2.2.1 Increased usage of reusable accessories in emerging economies to boost segment growth 141
TABLE 46 NON-DISPOSABLE ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
7 BRAIN MONITORING MARKET, BY PROCEDURE 142
7.1 INTRODUCTION 143
TABLE 47 BRAIN MONITORING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 143
7.1.1 NON-INVASIVE PROCEDURES 143
7.1.1.1 Limited risk of infections and hemorrhage to drive market 143
TABLE 48 BRAIN MONITORING MARKET FOR NON-INVASIVE PROCEDURES, BY COUNTRY, 2021–2028 (USD MILLION) 144
7.1.2 INVASIVE PROCEDURES 144
7.1.2.1 Higher resolution imaging and detailed disease information to propel market 144
TABLE 49 BRAIN MONITORING MARKET FOR INVASIVE PROCEDURES, BY COUNTRY, 2021–2028 (USD MILLION) 145
8 BRAIN MONITORING MARKET, BY MODALITY 146
8.1 INTRODUCTION 147
TABLE 50 BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 147
8.2 FIXED DEVICES 147
8.2.1 HIGH ACCURACY, MORE RELIABILITY, AND BETTER DIAGNOSIS TO AID MARKET GROWTH 147
TABLE 51 BRAIN MONITORING MARKET FOR FIXED DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 148
8.3 PORTABLE DEVICES 148
8.3.1 INCREASED MOBILITY AND COMFORT TO PROPEL MARKET GROWTH 148
TABLE 52 BRAIN MONITORING MARKET FOR PORTABLE DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 149
8.4 WEARABLE DEVICES 149
8.4.1 GREATER CONVENIENCE AND CONTINUOUS DATA COLLECTION TO DRIVE MARKET GROWTH 149
TABLE 53 BRAIN MONITORING MARKET FOR WEARABLE DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 150
9 BRAIN MONITORING MARKET, BY MEDICAL CONDITION 151
9.1 INTRODUCTION 152
TABLE 54 COMPANIES OFFERING DEVICES FOR DIFFERENT MEDICAL CONDITIONS 152
TABLE 55 BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 152
9.2 TRAUMATIC BRAIN INJURY 153
9.2.1 GROWING INCIDENCE ACROSS ALL AGE GROUPS TO DRIVE MARKET 153
TABLE 56 BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURY, BY COUNTRY, 2021–2028 (USD MILLION) 154
9.3 STROKE 154
9.3.1 GROWING GERIATRIC POPULATION AND RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO SUPPORT MARKET GROWTH 154
TABLE 57 BRAIN MONITORING MARKET FOR STROKE, BY COUNTRY, 2021–2028 (USD MILLION) 155
9.4 DEMENTIA 156
9.4.1 FAVORABLE GOVERNMENT INITIATIVES AND INCREASED ACCESS TO TREATMENT TO DRIVE MARKET 156
TABLE 58 BRAIN MONITORING MARKET FOR DEMENTIA, BY COUNTRY, 2021–2028 (USD MILLION) 157
9.5 HEADACHE DISORDERS 157
9.5.1 RISING NUMBER OF INITIATIVES FOR HEADACHE DISORDERS TO PROPEL MARKET 157
TABLE 59 BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION) 158
9.6 SLEEP DISORDERS 159
9.6.1 INCREASED STRESS AND UNHEALTHY LIFESTYLES AMONG ADULTS TO DRIVE MARKET 159
TABLE 60 BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION) 160
9.7 PARKINSON’S DISEASE 160
9.7.1 INCREASING GERIATRIC POPULATION TO AID MARKET GROWTH 160
TABLE 61 BRAIN MONITORING MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2028 (USD MILLION) 161
9.8 EPILEPSY 161
9.8.1 RISING OCCURRENCE OF EPILEPSY AMONG ALL AGE GROUPS TO SUPPORT MARKET GROWTH 161
TABLE 62 BRAIN MONITORING MARKET FOR EPILEPSY, BY COUNTRY, 2021–2028 (USD MILLION) 162
9.9 HUNTINGTON’S DISEASE 162
9.9.1 AVAILABILITY OF ADVANCED TREATMENT AND ONGOING RESEARCH TO AID MARKET GROWTH 162
TABLE 63 BRAIN MONITORING MARKET FOR HUNTINGTON’S DISEASE, BY COUNTRY, 2021–2028 (USD MILLION) 163
9.10 OTHER MEDICAL CONDITIONS 163
TABLE 64 BRAIN MONITORING MARKET FOR OTHER MEDICAL CONDITIONS, BY COUNTRY, 2021–2028 (USD MILLION) 164
10 BRAIN MONITORING MARKET, BY END USER 165
10.1 INTRODUCTION 166
TABLE 65 BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 166
10.2 HOSPITALS 167
10.2.1 HOSPITALS TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD 167
TABLE 66 BRAIN MONITORING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 168
10.3 NEUROLOGY CENTERS 168
10.3.1 PRESENCE OF HIGHLY EFFICIENT AND ADVANCED BRAIN MONITORING DEVICES TO PROPEL MARKET 168
TABLE 67 BRAIN MONITORING MARKET FOR NEUROLOGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 169
10.4 DIAGNOSTIC CENTERS 169
10.4.1 FOCUS ON EARLY DIAGNOSIS AND TREATMENT OF NEUROGENERATIVE DISORDERS TO SUPPORT MARKET GROWTH 169
TABLE 68 BRAIN MONITORING MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 170
10.5 AMBULATORY SURGERY CENTERS & CLINICS 170
10.5.1 COST-EFFECTIVE AND MORE CONVENIENT TREATMENT OPTIONS TO AID MARKET GROWTH 170
TABLE 69 BRAIN MONITORING MARKET FOR AMBULATORY SURGERY CENTERS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 171
10.6 OTHER END USERS 171
TABLE 70 BRAIN MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 172
11 BRAIN MONITORING MARKET, BY REGION 173
11.1 INTRODUCTION 174
TABLE 71 BRAIN MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION) 174
11.2 NORTH AMERICA 174
FIGURE 38 NORTH AMERICA: BRAIN MONITORING MARKET SNAPSHOT 175
TABLE 72 NORTH AMERICA: BRAIN MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 73 NORTH AMERICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 176
TABLE 74 NORTH AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 75 NORTH AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 76 NORTH AMERICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 77 NORTH AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 177
TABLE 78 NORTH AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 178
TABLE 79 NORTH AMERICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 178
TABLE 80 NORTH AMERICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 179
TABLE 81 NORTH AMERICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 179
11.2.1 NORTH AMERICA: RECESSION IMPACT 180
11.2.2 US 180
11.2.2.1 US to dominate North American brain monitoring market during forecast period 180
TABLE 82 US: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 181
TABLE 83 US: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 84 US: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 85 US: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 86 US: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 182
TABLE 87 US: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 183
TABLE 88 US: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 183
TABLE 89 US: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 183
TABLE 90 US: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 184
11.2.3 CANADA 184
11.2.3.1 Increasing number of hospitals and surgical centers to propel market 184
TABLE 91 CANADA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 185
TABLE 92 CANADA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 93 CANADA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 94 CANADA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 95 CANADA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 186
TABLE 96 CANADA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 187
TABLE 97 CANADA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 187
TABLE 98 CANADA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 187
TABLE 99 CANADA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 188
11.3 EUROPE 188
FIGURE 39 EUROPE: BRAIN MONITORING MARKET SNAPSHOT 189
TABLE 100 EUROPE: BRAIN MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 190
TABLE 101 EUROPE: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 190
TABLE 102 EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 103 EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 104 EUROPE: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 105 EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 192
TABLE 106 EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 192
TABLE 107 EUROPE: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 193
TABLE 108 EUROPE: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 193
TABLE 109 EUROPE: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 194
11.3.1 EUROPE: RECESSION IMPACT 194
11.3.2 GERMANY 194
11.3.2.1 Growing geriatric population and increasing life expectancy to aid market growth 194
TABLE 110 GERMANY: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 195
TABLE 111 GERMANY: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 112 GERMANY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 113 GERMANY: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 114 GERMANY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 196
TABLE 115 GERMANY: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 197
TABLE 116 GERMANY: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 197
TABLE 117 GERMANY: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 197
TABLE 118 GERMANY: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 198
11.3.3 FRANCE 198
11.3.3.1 Increasing prevalence of neurological disorders to drive market 198
TABLE 119 FRANCE: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 199
TABLE 120 FRANCE: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 121 FRANCE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 122 FRANCE: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 123 FRANCE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 200
TABLE 124 FRANCE: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 201
TABLE 125 FRANCE: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 201
TABLE 126 FRANCE: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 201
TABLE 127 FRANCE: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 202
11.3.4 UK 202
11.3.4.1 Increasing R&D investments by public and private sectors to boost market growth 202
TABLE 128 UK: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 203
TABLE 129 UK: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 130 UK: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 131 UK: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 132 UK: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 204
TABLE 133 UK: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 205
TABLE 134 UK: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 205
TABLE 135 UK: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 205
TABLE 136 UK: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 206
11.3.5 ITALY 206
11.3.5.1 Rising incidence of neurological disorders in aging population to drive market 206
TABLE 137 ITALY: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 206
TABLE 138 ITALY: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 139 ITALY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 140 ITALY: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 141 ITALY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 208
TABLE 142 ITALY: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 208
TABLE 143 ITALY: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 209
TABLE 144 ITALY: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 209
TABLE 145 ITALY: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 210
11.3.6 SPAIN 210
11.3.6.1 Increased burden of Parkinson’s disease to propel market 210
TABLE 146 SPAIN: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 210
TABLE 147 SPAIN: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 148 SPAIN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 149 SPAIN: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 150 SPAIN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 212
TABLE 151 SPAIN: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 212
TABLE 152 SPAIN: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 213
TABLE 153 SPAIN: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 213
TABLE 154 SPAIN: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 214
11.3.7 REST OF EUROPE 214
TABLE 155 REST OF EUROPE: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 215
TABLE 156 REST OF EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 157 REST OF EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 158 REST OF EUROPE: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 159 REST OF EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 216
TABLE 160 REST OF EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 217
TABLE 161 REST OF EUROPE: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 217
TABLE 162 REST OF EUROPE: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 217
TABLE 163 REST OF EUROPE: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 218
 
11.4 ASIA PACIFIC 218
TABLE 164 ASIA PACIFIC: BRAIN MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 218
TABLE 165 ASIA PACIFIC: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 219
TABLE 166 ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 167 ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 168 ASIA PACIFIC: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 169 ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 220
TABLE 170 ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 221
TABLE 171 ASIA PACIFIC: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 221
TABLE 172 ASIA PACIFIC: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 221
TABLE 173 ASIA PACIFIC: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 222
11.4.1 ASIA PACIFIC: RECESSION IMPACT 222
11.4.2 JAPAN 222
11.4.2.1 High incidence of neurological disorders and large geriatric population to drive market 222
TABLE 174 JAPAN: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 223
TABLE 175 JAPAN: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 176 JAPAN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 177 JAPAN: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 178 JAPAN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 224
TABLE 179 JAPAN: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 225
TABLE 180 JAPAN: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 225
TABLE 181 JAPAN: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 225
TABLE 182 JAPAN: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 226
11.4.3 CHINA 226
11.4.3.1 Increasing number of government initiatives and growing incidence of neurological disorders to drive market 226
TABLE 183 CHINA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 227
TABLE 184 CHINA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 185 CHINA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 186 CHINA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 187 CHINA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 228
TABLE 188 CHINA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 229
TABLE 189 CHINA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 229
TABLE 190 CHINA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 229
TABLE 191 CHINA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 230
11.4.4 INDIA 230
11.4.4.1 Improving healthcare infrastructure and rising public-private investment to support market growth 230
TABLE 192 INDIA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 230
TABLE 193 INDIA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 194 INDIA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 195 INDIA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 196 INDIA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 232
TABLE 197 INDIA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 232
TABLE 198 INDIA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 233
TABLE 199 INDIA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 233
TABLE 200 INDIA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 234
11.4.5 REST OF ASIA PACIFIC 234
TABLE 201 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 234
TABLE 202 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 203 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 204 REST OF ASIA PACIFIC: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 205 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 236
TABLE 206 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 236
TABLE 207 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 237
TABLE 208 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 237
TABLE 209 REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 238

11.5 LATIN AMERICA 238
TABLE 210 LATIN AMERICA: BRAIN MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION) 239
TABLE 211 LATIN AMERICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 239
TABLE 212 LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 213 LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 214 LATIN AMERICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 215 LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 240
TABLE 216 LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 241
TABLE 217 LATIN AMERICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 241
TABLE 218 LATIN AMERICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 241
TABLE 219 LATIN AMERICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 242
11.5.1 LATIN AMERICA: RECESSION IMPACT 242
11.5.2 BRAZIL 242
11.5.2.1 High cost of brain monitoring and imaging modalities to limit market growth 242
TABLE 220 BRAZIL: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 243
TABLE 221 BRAZIL: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 222 BRAZIL: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 223 BRAZIL: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 224 BRAZIL: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 244
TABLE 225 BRAZIL: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 245
TABLE 226 BRAZIL: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 245
TABLE 227 BRAZIL: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 245
TABLE 228 BRAZIL: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 246
11.5.3 MEXICO 246
11.5.3.1 Low tax rates and strong healthcare infrastructure to support market growth 246
TABLE 229 MEXICO: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 247
TABLE 230 MEXICO: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 231 MEXICO: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 232 MEXICO: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 233 MEXICO: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 248
TABLE 234 MEXICO: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 249
TABLE 235 MEXICO: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 249
TABLE 236 MEXICO: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 249
TABLE 237 MEXICO: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 250
11.5.4 REST OF LATIN AMERICA 250
TABLE 238 REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 251
TABLE 239 REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 251
TABLE 240 REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 241 REST OF LATIN AMERICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 242 REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 252
TABLE 243 REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 253
TABLE 244 REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 253
TABLE 245 REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 253
TABLE 246 REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 254
11.6 MIDDLE EAST & AFRICA 254
TABLE 247 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION) 255
TABLE 248 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 255
TABLE 249 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 250 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 251 MIDDLE EAST & AFRICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 252 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 256
TABLE 253 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 257
TABLE 254 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 257
TABLE 255 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 257
TABLE 256 MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 258
11.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT 258
11.6.2 GCC COUNTRIES 258
11.6.2.1 Rising prevalence of Alzheimer’s and increasing number of government initiatives to drive market 258
TABLE 257 GCC COUNTRIES: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 259
TABLE 258 GCC COUNTRIES: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 259
TABLE 259 GCC COUNTRIES: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 260
TABLE 260 GCC COUNTRIES: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 260
TABLE 261 GCC COUNTRIES: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 260
TABLE 262 GCC COUNTRIES: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 261
TABLE 263 GCC COUNTRIES: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 261
TABLE 264 GCC COUNTRIES: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 261
TABLE 265 GCC COUNTRIES: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 262
11.6.3 REST OF MIDDLE EAST & AFRICA 262
TABLE 266 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 262
TABLE 267 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 263
TABLE 268 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 263
TABLE 269 REST OF MIDDLE EAST & AFRICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 264
TABLE 270 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION) 264
TABLE 271 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 264
TABLE 272 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 265
TABLE 273 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 265
TABLE 274 REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 266
12 COMPETITIVE LANDSCAPE 267
12.1 INTRODUCTION 267
12.2 KEY STRATEGIES/RIGHT TO WIN 267
TABLE 275 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BRAIN MONITORING MARKET 267
12.3 REVENUE SHARE ANALYSIS 269
12.4 MARKET SHARE ANALYSIS 270
FIGURE 41 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 270
TABLE 276 DEGREE OF COMPETITION IN BRAIN MONITORING MARKET 271
FIGURE 42 RANKING OF KEY COMPANIES IN BRAIN MONITORING MARKET, 2022 271
12.5 COMPANY EVALUATION MATRIX 272
12.5.1 STARS 272
12.5.2 EMERGING LEADERS 273
12.5.3 PERVASIVE PLAYERS 273
12.5.4 PARTICIPANTS 273
FIGURE 43 COMPANY EVALUATION MATRIX, 2022 273
12.5.5 COMPANY FOOTPRINT 274
12.5.5.1 Overall footprint 274
TABLE 277 BRAIN MONITORING MARKET: OVERALL FOOTPRINT 274
12.5.5.2 Product footprint 275
TABLE 278 BRAIN MONITORING MARKET: PRODUCT FOOTPRINT 275
12.5.5.3 Procedure footprint 276
TABLE 279 BRAIN MONITORING MARKET: PROCEDURE FOOTPRINT 276
12.5.5.4 Modality footprint 277
TABLE 280 BRAIN MONITORING MARKET: MODALITY FOOTPRINT 277
12.5.5.5 Medical condition footprint 278
TABLE 281 BRAIN MONITORING MARKET: MEDICAL CONDITION FOOTPRINT 278
12.5.5.6 End user footprint 279
TABLE 282 BRAIN MONITORING MARKET: END USER FOOTPRINT 279
12.5.5.7 Regional footprint 280
TABLE 283 BRAIN MONITORING MARKET: REGIONAL FOOTPRINT 280
12.6 START-UP/SME EVALUATION MATRIX 281
12.6.1 PROGRESSIVE COMPANIES 281
12.6.2 RESPONSIVE COMPANIES 281
12.6.3 DYNAMIC COMPANIES 281
12.6.4 STARTING BLOCKS 281
FIGURE 44 START-UP/SME EVALUATION MATRIX, 2022 282
12.6.5 COMPETITIVE BENCHMARKING 282
TABLE 284 DETAILED LIST OF KEY START-UPS/SMES IN BRAIN MONITORING MARKET 282
12.7 COMPETITIVE SCENARIO 283
12.7.1 PRODUCT LAUNCHES & APPROVALS 283
TABLE 285 BRAIN MONITORING MARKET: PRODUCT LAUNCHES & APPROVALS, 2020–2024 283
12.7.2 DEALS 285
TABLE 286 BRAIN MONITORING MARKET: DEALS, 2020–2024 285
12.7.3 OTHER DEVELOPMENTS 286
TABLE 287 BRAIN MONITORING MARKET: OTHER DEVELOPMENTS, 2020–2024 286
13 COMPANY PROFILES 287
13.1 KEY PLAYERS 287
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 NATUS MEDICAL INCORPORATED 287
TABLE 289 NATUS MEDICAL INCORPORATED: DEALS, 2020–2024 290
13.1.2 NIHON KOHDEN CORPORATION 291
TABLE 290 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 291
FIGURE 45 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022) 292
TABLE 291 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES &
APPROVALS, 2020–2024 293
13.1.3 PHILIPS HEALTHCARE 294
TABLE 292 PHILIPS HEALTHCARE: COMPANY OVERVIEW 294
FIGURE 46 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2022) 295
TABLE 293 PHILIPS HEALTHCARE: DEALS, 2020–2024 297
13.1.4 GE HEALTHCARE 298
TABLE 294 GE HEALTHCARE: COMPANY OVERVIEW 298
FIGURE 47 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 299
TABLE 295 GE HEALTHCARE: DEALS, 2020–2024 301
13.1.5 SIEMENS HEALTHINEERS AG 303
TABLE 296 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 303
FIGURE 48 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023) 304
TABLE 297 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & APPROVALS, 2020–2024 305
TABLE 298 SIEMENS HEALTHINEERS AG: DEALS, 2020–2024 306
13.1.6 COMPUMEDICS LIMITED 307
TABLE 299 COMPUMEDICS LIMITED: COMPANY OVERVIEW 307
FIGURE 49 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2022) 307
TABLE 300 COMPUMEDICS LIMITED: PRODUCT LAUNCHES & APPROVALS, 2020–2024 310
TABLE 301 COMPUMEDICS LIMITED: DEALS, 2020–2024 310
13.1.7 MEDTRONIC 311
TABLE 302 MEDTRONIC: COMPANY OVERVIEW 311
FIGURE 50 MEDTRONIC: COMPANY SNAPSHOT (2023) 312
13.1.8 EDWARDS LIFESCIENCES CORPORATION 314
TABLE 303 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW 314
FIGURE 51 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2022) 315
13.1.9 ADVANCED BRAIN MONITORING, INC. 318
TABLE 304 ADVANCED BRAIN MONITORING, INC.: COMPANY OVERVIEW 318
13.1.10 CADWELL INDUSTRIES, INC. 319
TABLE 305 CADWELL INDUSTRIES, INC: COMPANY OVERVIEW 319
TABLE 306 CADWELL INDUSTRIES, INC.: PRODUCT LAUNCHES & APPROVALS, 2020–2024 320
TABLE 307 CADWELL INDUSTRIES, INC.: DEALS, 2020–2024 320
13.1.11 NEUROWAVE SYSTEMS, INC. 321
TABLE 308 NEUROWAVE SYSTEMS, INC.: COMPANY OVERVIEW 321
13.1.12 NEUROSOFT 322
TABLE 309 NEUROSOFT: COMPANY OVERVIEW 322
13.1.13 CGX 324
TABLE 310 CGX: COMPANY OVERVIEW 324
TABLE 311 CGX: OTHER DEVELOPMENTS, 2020–2024 324
13.1.14 NONIN 325
TABLE 312 NONIN: COMPANY OVERVIEW 325
13.1.15 RIMED 326
TABLE 313 RIMED: COMPANY OVERVIEW 326
TABLE 314 RIMED: DEALS, 2020–2024 326
13.1.16 EMOTIV 327
TABLE 315 EMOTIV: COMPANY OVERVIEW 327
13.1.17 DRÄGERWERK AG & CO. KGAA 328
TABLE 316 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 328
FIGURE 52 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2022) 328
13.1.18 MASIMO CORPORATION 330
TABLE 317 MASIMO CORPORATION: COMPANY OVERVIEW 330
FIGURE 53 MASIMO CORPORATION: COMPANY SNAPSHOT (2021) 330
TABLE 318 MASIMO CORPORATION: DEALS, 2020–2024 331
13.1.19 LUCIOLE MEDICAL AG 332
TABLE 319 LUCIOLE MEDICAL AG: COMPANY OVERVIEW 332
TABLE 320 LUCIOLE MEDICAL AG: DEALS, 2020–2024 333
13.1.20 INTEGRA LIFESCIENCES 334
TABLE 321 INTEGRA LIFESCIENCES: COMPANY OVERVIEW 334
FIGURE 54 INTEGRA LIFE SCIENCES: COMPANY SNAPSHOT (2022) 335
13.2 OTHER PLAYERS 336
13.2.1 INFRASCAN, INC. 336
13.2.2 NEUSOFT MEDICAL SYSTEMS CO., LTD. 337
13.2.3 NORAXON USA 338
13.2.4 STERNMED GMBH 339
13.2.5 CERIBELL 339
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 340
14.1 DISCUSSION GUIDE 340
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 345
14.3 CUSTOMIZATION OPTIONS 347
14.4 RELATED REPORTS 347
14.5 AUTHOR DETAILS 348

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 患者ポジショニングシステムの世界市場予測（～2027）：製品別（テーブル（手術台、イメージングテーブル、検査台）、付属品別、用途別、エンドユーザー別
  • 放射線量管理の世界市場予測（～2028）：提供別、モダリティ別、収益モデル別、用途別、エンドユーザー別
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MD1369-24 )"脳モニタリングの世界市場予測（～2028）：機器別、付属品別、モダリティ別、疾患別、エンドユーザー別" (英文：Brain Monitoring Market by Devices (EEG, EMG, MEG, ICP, MRI, fMRI, CT) Accessories (Electrode, Sensor), Modality (Portable, Wearable), Indication (Stroke, TBI, Epilepsy, Headache, Sleep), End User (Hospital, Neurology center) - Global Forecast to 2028)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。